Hepatocellular carcinoma (HCC) cases are underreported in India. Our study was designed to investigate the etiological profile of HCC cases in India and compare with global incidence. The study included 348 HCC and 375 chronic liver disease cases without HCC as controls. Samples were screened for hepatitis B virus (HBV)/hepatitis C virus (HCV) infections using enzymelinked immunosorbent assay and polymerase chain reaction (PCR). HBV-DNA and HCV-RNA genotyping was performed by PCR-restriction fragment length polymorphism. All cases were also assessed for other possible risk factors of HCC. Among HCC cases, 62.6% were positive for HBV, 26.7% for HCV and 3.2% had coinfection. Around 17% of HCC cases had aflatoxin-B1 exposure. HBV genotype D (odds ratio, OR 5 1.76) and mixed genotypes (OR 5 6.86) had higher risk of HCC development. The risk of HCC was twofold (OR 5 2.26) in patients with high HBV-DNA levels. Moreover, our findings were unable to establish a clear differential effect of HCV genotype (OR 5 1.48) and high viral load (OR 5 1.21) on HCC development. In India, HBV is the major risk factors, whereas alcohol, smoking and diabetes are nonsignificantly associated. Asian countries such as Hong Kong and Taiwan also had high incidence of HBV-related HCC. Contrarily, countries from Europe and USA reported HCV as predominant cause of HCC. Further, aflatoxin could be a possible risk of HCC in the population. However, in comparison to the countries such as China and Taiwan (high Aflatoxin exposure), the aflatoxin level is relatively low in our patients. High HBV-DNA levels and HBV/D increased the risk of HCC. However, neither genotype nor virus loads of HCV affected prognosis of HCC patients in our study.Primary liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality. 1 Most hepatocellular carcinoma (HCC) cases (>80%) occur in either sub-Saharan Africa or in Eastern Asia. 2 Most Asian countries are in the intermediate to high incidence zone of HCC. However, India falls in the low incidence zone. 2 According to GLOBOCAN 2008 data, a total of 14,516 cases of HCC have been reported in India with an age-adjusted incidence rate of 3.2 per 1,00,000 population. 3 Sen et al. 4 reported an age-adjusted HCC incidence rate of 5.3 and relative frequency of 4.8% among males. However, among women, relative frequency of 3.1% and incidence rate of 3.9 have been observed in India. In comparison to the neighboring East Asian countries, the incidence of HCC in India was found to be relatively low. 4 The overall incidence of HCC in India does not fall within the ten leading sites of cancer in either sex. 5 The annual risk of HCC is 0.5% for asymptomatic HBsAg carriers and 0.8% for patients with chronic hepatitis B. 6 Most patients acquired the HBV infection as neonates. 7 The incidence of HCC was 2.7% in HBV-related compensated cirrhosis from Asia. In a cohort of 350 European patients with compensated cirrhosis, the 5-year cumulative incidence of HCC was 6%. 8,9 The incidence of HBV-re...